INMB Dec 2024 22.500 call
| Previous close | 1.4300 |
| Open | 1.4300 |
| Bid | 0.0000 |
| Ask | 1.6000 |
| Strike | 22.50 |
| Expiry date | 2024-12-20 |
| Day's range | 1.4300 - 1.4300 |
| Contract range | N/A |
| Volume | |
| Open interest | 46 |
GlobeNewswireINmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
The planned interim analysis confirms the accuracy of the sample size calculations and statistical power for EMACC, the primary endpoint. The interim analysis, performed by a third-party, demonstrated no need to change trial design or size. BOCA RATON, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today confirmed the Phas
- GlobeNewswire
INmune Bio Inc. to Join Russell 3000® Index
Boca Raton, Florida, May 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as o
Insider MonkeyINmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the […]
